Showing results (241-250 of 271) with videos related to

Sort By:
Pageof 28
Medicine|January 15, 2016
Loss of BAP1 Expression Occurs Frequently in Intrahepatic CholangiocarcinomaJuliana Andrici, Benjamin Goeppert, Loretta Sioson, et al.
British Journal of Cancer|November 23, 2013
Adjuvant chemotherapy in elderly patients with pancreatic cancerA M Nagrial, D K Chang, N Q Nguyen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2012
The prognostic and predictive value of serum CA19.9 in pancreatic cancerJ L Humphris, D K Chang, A L Johns, et al.
Annals of Surgery|February 6, 2023
The Impact of Molecular Subtyping on Pathological Staging of Pancreatic CancerStephan B Dreyer, Sarah Rae, Kirsty Bisset, et al.
Neuroendocrinology|August 3, 2021
International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine TumorsCharlotte M Heidsma, Stijn van Roessel, Susan van Dieren, et al.
Cancer|October 15, 2014
Clinical and pathologic features of familial pancreatic cancerJeremy L Humphris, Amber L Johns, Skye H Simpson, et al.
The Journal of Pathology|February 12, 2017
Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4Waki Hosoda, Peter Chianchiano, James F Griffin, et al.
Annals of Surgery|October 1, 2019
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine TumorsAlessandra Pulvirenti, Ammar A Javed, Luca Landoni, et al.
Clinical Epigenetics|June 9, 2015
The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brainRajendra P Pangeni, Prasanna Channathodiyil, David S Huen, et al.
Genome Medicine|April 30, 2017
Lost in translation: returning germline genetic results in genome-scale cancer researchAmber L Johns, Skye H McKay, Jeremy L Humphris, et al.
Pageof 28